Callos Andrew sold CYTK

February 2, 2026 · Form 4 insider transaction

Callos Andrew sold 886 shares of Cytokinetics, Incorporated at $62.10 per share, a transaction worth $55.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Disposed (sell-side)
Shares
886
Price
$62.10
Total value
$55.0K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 2, 2026
Filing dateFebruary 2, 2026
Shares owned after50,440
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR
Callos Andrew sold CYTK: February 2, 2026 | Insider Trading Screener